HUPRA syndrome: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
 
Line 1: Line 1:
{{SI}}
{{Infobox medical condition
| name            = HUPRA syndrome
| image          = [[File:Autosomal_recessive_-_en.svg|200px]]
| caption        = HUPRA syndrome is inherited in an [[autosomal recessive]] pattern.
| synonyms        = Hyperuricemia, pulmonary hypertension, renal failure in infancy, and alkalosis syndrome
| specialty      = [[Medical genetics]]
| symptoms        = [[Hyperuricemia]], [[pulmonary hypertension]], [[renal failure]], [[metabolic alkalosis]]
| onset          = Infancy
| duration        = Lifelong
| causes          = Mutations in the [[SARS2]] gene
| risks          = Family history of the condition
| diagnosis      = [[Genetic testing]], clinical evaluation
| treatment      = Supportive care, management of symptoms
| prognosis      = Poor, often fatal in early childhood
| frequency      = Extremely rare
}}
'''HUPRA syndrome''' is a rare genetic disorder characterized by [[hyperuricemia]], [[pulmonary hypertension]], [[renal failure]] in infancy, and [[alkalosis]]. It was first described in 2010 and is caused by mutations in the [[SLC22A12]] gene, which encodes the [[uric acid]] transporter URAT1.
'''HUPRA syndrome''' is a rare genetic disorder characterized by [[hyperuricemia]], [[pulmonary hypertension]], [[renal failure]] in infancy, and [[alkalosis]]. It was first described in 2010 and is caused by mutations in the [[SLC22A12]] gene, which encodes the [[uric acid]] transporter URAT1.
==Symptoms and Signs==
==Symptoms and Signs==
The symptoms of HUPRA syndrome typically present in infancy and include failure to thrive, [[dyspnea]] (difficulty breathing), and [[edema]] (swelling). Laboratory tests often reveal high levels of uric acid in the blood (hyperuricemia), low levels of bicarbonate in the blood (metabolic acidosis), and evidence of kidney damage.
The symptoms of HUPRA syndrome typically present in infancy and include failure to thrive, [[dyspnea]] (difficulty breathing), and [[edema]] (swelling). Laboratory tests often reveal high levels of uric acid in the blood (hyperuricemia), low levels of bicarbonate in the blood (metabolic acidosis), and evidence of kidney damage.
==Genetics==
==Genetics==
HUPRA syndrome is caused by mutations in the SLC22A12 gene, which is located on [[chromosome 11]]. This gene encodes the protein URAT1, which is responsible for reabsorbing uric acid from the urine back into the blood. Mutations in this gene disrupt the function of URAT1, leading to an overproduction of uric acid and the symptoms of HUPRA syndrome.
HUPRA syndrome is caused by mutations in the SLC22A12 gene, which is located on [[chromosome 11]]. This gene encodes the protein URAT1, which is responsible for reabsorbing uric acid from the urine back into the blood. Mutations in this gene disrupt the function of URAT1, leading to an overproduction of uric acid and the symptoms of HUPRA syndrome.
==Diagnosis==
==Diagnosis==
The diagnosis of HUPRA syndrome is based on the clinical symptoms, laboratory findings, and genetic testing. Genetic testing can confirm the presence of mutations in the SLC22A12 gene.
The diagnosis of HUPRA syndrome is based on the clinical symptoms, laboratory findings, and genetic testing. Genetic testing can confirm the presence of mutations in the SLC22A12 gene.
==Treatment==
==Treatment==
There is currently no cure for HUPRA syndrome. Treatment is supportive and aims to manage the symptoms. This may include medications to lower uric acid levels, oxygen therapy for pulmonary hypertension, and dialysis or kidney transplant for renal failure.
There is currently no cure for HUPRA syndrome. Treatment is supportive and aims to manage the symptoms. This may include medications to lower uric acid levels, oxygen therapy for pulmonary hypertension, and dialysis or kidney transplant for renal failure.
==Prognosis==
==Prognosis==
The prognosis for individuals with HUPRA syndrome is poor, with most individuals not surviving past infancy. However, early diagnosis and management of symptoms can improve quality of life and potentially extend lifespan.
The prognosis for individuals with HUPRA syndrome is poor, with most individuals not surviving past infancy. However, early diagnosis and management of symptoms can improve quality of life and potentially extend lifespan.
==See Also==
==See Also==
* [[Hyperuricemia]]
* [[Hyperuricemia]]
Line 24: Line 35:
* [[Uric acid]]
* [[Uric acid]]
* [[Chromosome 11]]
* [[Chromosome 11]]
[[Category:Rare diseases]]
[[Category:Rare diseases]]
[[Category:Genetic disorders]]
[[Category:Genetic disorders]]
Line 34: Line 44:
{{Metabolic disorders}}
{{Metabolic disorders}}
[[Category:Syndromes]] {{stub}}
[[Category:Syndromes]] {{stub}}
<gallery>
File:Autosomal_recessive_-_en.svg|Autosomal recessive inheritance pattern
</gallery>

Latest revision as of 20:27, 6 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC

HUPRA syndrome
Synonyms Hyperuricemia, pulmonary hypertension, renal failure in infancy, and alkalosis syndrome
Pronounce N/A
Specialty Medical genetics
Symptoms Hyperuricemia, pulmonary hypertension, renal failure, metabolic alkalosis
Complications N/A
Onset Infancy
Duration Lifelong
Types N/A
Causes Mutations in the SARS2 gene
Risks Family history of the condition
Diagnosis Genetic testing, clinical evaluation
Differential diagnosis N/A
Prevention N/A
Treatment Supportive care, management of symptoms
Medication N/A
Prognosis Poor, often fatal in early childhood
Frequency Extremely rare
Deaths N/A


HUPRA syndrome is a rare genetic disorder characterized by hyperuricemia, pulmonary hypertension, renal failure in infancy, and alkalosis. It was first described in 2010 and is caused by mutations in the SLC22A12 gene, which encodes the uric acid transporter URAT1.

Symptoms and Signs[edit]

The symptoms of HUPRA syndrome typically present in infancy and include failure to thrive, dyspnea (difficulty breathing), and edema (swelling). Laboratory tests often reveal high levels of uric acid in the blood (hyperuricemia), low levels of bicarbonate in the blood (metabolic acidosis), and evidence of kidney damage.

Genetics[edit]

HUPRA syndrome is caused by mutations in the SLC22A12 gene, which is located on chromosome 11. This gene encodes the protein URAT1, which is responsible for reabsorbing uric acid from the urine back into the blood. Mutations in this gene disrupt the function of URAT1, leading to an overproduction of uric acid and the symptoms of HUPRA syndrome.

Diagnosis[edit]

The diagnosis of HUPRA syndrome is based on the clinical symptoms, laboratory findings, and genetic testing. Genetic testing can confirm the presence of mutations in the SLC22A12 gene.

Treatment[edit]

There is currently no cure for HUPRA syndrome. Treatment is supportive and aims to manage the symptoms. This may include medications to lower uric acid levels, oxygen therapy for pulmonary hypertension, and dialysis or kidney transplant for renal failure.

Prognosis[edit]

The prognosis for individuals with HUPRA syndrome is poor, with most individuals not surviving past infancy. However, early diagnosis and management of symptoms can improve quality of life and potentially extend lifespan.

See Also[edit]

NIH genetic and rare disease info[edit]

HUPRA syndrome is a rare disease.








This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia